Ray Dalio’s Dorman Products DORM Stock Holding History

Ray Dalio’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,306	Closed	-$1.89M	–	1067
2025 Q4	$1.89M	Buy	15,306 +11,190	+272%	+$1.51M	0.01%	778
2025 Q3	$642K	Buy	+4,116	New	+$590K	﹤0.01%	899

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ray Dalio's DORM Position: Q1 2026 in Review

Ray Dalio sold out of Dorman Products (DORM) in Q1 2026, closing a stake of 15,306 shares — an estimated $1.89M sold.

Ray Dalio first reported a position in DORM in Q3 2025 and held it in 2 quarters. The position peaked at $1.89M in Q4 2025. 318 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

Ray Dalio reported no remaining Dorman Products position as of Q1 2026 after selling out during the quarter.
Ray Dalio sold 15,306 Dorman Products shares in Q1 2026, an estimated $1.89M.
Ray Dalio first reported a position in Dorman Products in Q3 2025 and held it in 2 quarters.
Ray Dalio's Dorman Products position peaked at $1.89M in Q4 2025.
318 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.